Publication

Ligand-specific deactivation time course of GluN1/GluN2D NMDA receptors

Downloadable Content

Persistent URL
Last modified
  • 05/15/2025
Type of Material
Authors
    Katie M. Vance, Emory UniversityNoriko Simorowski, Cold Spring Harbor LaboratoryStephen Traynelis, Emory UniversityHiro Furukawa, Cold Spring Harbor Laboratory
Language
  • English
Date
  • 2011-04-01
Publisher
  • Nature Research (part of Springer Nature): Fully open access journals
Publication Version
Copyright Statement
  • © 2011 Macmillan Publishers Limited. All rights reserved.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 2041-1723
Volume
  • 2
Issue
  • 1
Start Page
  • 294
End Page
  • 294
Grant/Funding Information
  • HF is also supported by a new investigator research grant from Alzheimer’s Association.
  • This work was supported by the NINDS (NS036654, NS065371 to SFT); NIH training grants (T32-ES012870 and T32-DA01504006, KMV); NIMH (MH085926-01A1 to HF).
Supplemental Material (URL)
Abstract
  • N-methyl-D-aspartate (NMDA) receptors belong to the family of ionotropic glutamate receptors that mediate a majority of excitatory synaptic transmission. One unique property of GluN1/GluN2D NMDA receptors is an unusually prolonged deactivation time course following the removal of L-glutamate. Here we show, using x-ray crystallography and electrophysiology, that the deactivation time course of GluN1/GluN2D receptors is influenced by the conformational variability of the ligand-binding domain (LBD) as well as the structure of the activating ligand. L-glutamate and L-CCG-IV induce significantly slower deactivation time courses compared with other agonists. Crystal structures of the isolated GluN2D LBD in complex with various ligands reveal that the binding of L-glutamate induces a unique conformation at the backside of the ligand-binding site in proximity to the region at which the transmembrane domain would be located in the intact receptors. These data suggest that the activity of the GluN1/GluN2D NMDA receptor is controlled distinctively by the endogenous neurotransmitter L-glutamate.
Author Notes
  • Dr. Hiro Furukawa, Cold Spring Harbor Laboratory, Keck Structural Biology Laboratory, 1 Bungtown Rd., Cold Spring Harbor, NY, 11724, USA. Tel: 516-316-8872; Fax: 516-316-8873; furukawa@cshl.edu.
Keywords
Research Categories
  • Biology, Physiology
  • Health Sciences, Pharmacology

Tools

Relations

In Collection:

Items